Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on January 25, 2007

Arteriosclerosis, Thrombosis, and Vascular Biology. 2007
Published online before print January 25, 2007, doi: 10.1161/01.ATV.0000258794.57872.3f
A more recent version of this article appeared on April 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/4/901    most recent
01.ATV.0000258794.57872.3fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blanc-Brude, O. P.
Right arrow Articles by Tedgui, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blanc-Brude, O. P.
Right arrow Articles by Tedgui, A.

Submitted on August 24, 2006
Accepted on December 21, 2006

IAP Survivin Regulates Atherosclerotic Macrophage Survival

Olivier P. Blanc-Brude *; Elisabeth Teissier ; Yves Castier ; Guy Lesèche ; Ann-Pascal Bijnens ; Mat Daemen ; Bart Staels ; Ziad Mallat ; and Alain Tedgui

From Centre de Recherche Cardiovasculaire Inserm-Lariboisère U689, (O.P.B.-B., Z.M., A.T.) Hôpital Lariboisière, Paris, France; INSERM U325 (E.T., B.S.), Institut Pasteur de Lille, Lille, France; Service de Chirurgie Vasculaire et Thoracique (Y.C., G.L.), Hôpital Bichat-Claude Bernard, Paris, France; Cardiovascular Research Institute Maastricht (CARIM) (A.-P.B., M.D.), University of Maastricht, Maastricht, The Netherlands.

* To whom correspondence should be addressed. E-mail: olivier.blanc-brude{at}larib.inserm.fr.

Objectives--Inflammatory macrophage apoptosis is critical to atherosclerotic plaque formation, but its mechanisms remain enigmatic. We hypothesized that inhibitor of apoptosis protein (IAP) survivin regulates macrophage death in atherosclerosis.

Methods and Results--Western blot analysis revealed discrete survivin expression in human aorta lipid streaks but virtually none in advanced atherosclerotic plaques, despite increased XIAP and cIAP2 levels. Survivin was detected in CD68-positive macrophages infiltrating human lipid streaks by immunohistochemistry. In advanced atherosclerotic plaques, only rare macrophages outside the necrotic core or occasional fibrous cap smooth muscle cells expressed survivin. In vitro, macrophage colony-stimulating factor-stimulated mouse macrophage survivin expression, proliferation and resistance to apoptosis. Conversely, prolonged oxidized low-density lipoprotein treatment abolished macrophage survivin expression and triggered apoptosis after 12 hours, despite enhanced XIAP and cIAP2 expression. Adenoviral overexpression of survivin conferred macrophages with sustained resistance to apoptosis after oxidized low-density lipoprotein, tumor necrosis factor-{alpha}, or staurosporine challenge.

Conclusions--Survivin is a critical modulator of atherosclerotic macrophage apoptosis under dual control by growth factors and oxidized lipids accumulating in atheroma. In early lipid streaks, growth factor-stimulated survivin expression may contribute to macrophage accumulation and survival, but dysregulation of survivin expression caused by recurrent oxidized low-density lipoprotein exposure may favor apoptosis in advanced atherosclerotic plaques despite upregulated cIAP2 and XIAP.


Key words: apoptosis • atherosclerosis • inflammation • leukocytes